The p.R66W Variant in RAC3 Causes Severe Fetopathy Through Variant-Specific Mechanisms
Cells · 2024
DOI: 10.3390/cells13232032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Ryota Sugawara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya, Kasugai 480-0392, Ja…. Hauptthemen laut MEDLINE: rac GTP-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (B), Grant-in-Aid for Challenging Exploratory Research.
Abstract (Originalsprache)
RAC3 encodes a small GTPase of the Rho family that plays a critical role in actin cytoskeleton remodeling and intracellular signaling regulation. Pathogenic variants in RAC3, all of which reported thus far affect conserved residues within its functional domains, have been linked to neurodevelopmental disorders characterized by diverse phenotypic features, including structural brain anomalies and facial dysmorphism (NEDBAF). Recently, a novel de novo RAC3 variant (NM_005052.3): c.196C>T, p.R66W was identified in a prenatal case with fetal akinesia deformation sequence (a spectrum of conditions that interfere with the fetus’s ability to move), and complex brain malformations featuring corpus callosum agenesis, diencephalosynapsis, kinked brainstem, and vermian hypoplasia. To investigate the mechanisms underlying the association between RAC3 deficiency and this unique, distinct clinical phenotype, we explored the pathophysiological significance of the p.R66W variant in brain development. Biochemical assays revealed a modest enhancement in intrinsic GDP/GTP exchange activity and an inhibitory effect on GTP hydrolysis. Transient expression studies in COS7 cells demonstrated that RAC3-R66W interacts with the downstream effectors PAK1, MLK2, and N-WASP but fails to activate SRF-, AP1-, and NFkB-mediated transcription. Additionally, overexpression of RAC3-R66W significantly impaired differentiation in primary cultured hippocampal neurons. Acute expression of RAC3-R66W in vivo by in utero electroporation resulted in impairments in cortical neuron migration and axonal elongation during corticogenesis. Collectively, these findings suggest that the p.R66W variant may function as an activated version in specific signaling pathways, leading to a distinctive and severe prenatal phenotype through variant-specific mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya, Kasugai 480-0392, Japan.
- United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido 1-1, Gifu 501-1193, Japan.
- Center for One Medicine Innovative Translational Research (COMIT), Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16147 Genoa, Italy.
- Department of Neurochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Nagoya 466-8550, Japan.
ORCID-Profile: Hidenori Ito, Hidenori Tabata, Marcello Scala, Koh-Ichi Nagata
Förderung
- Japan Society for the Promotion of Science
- Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (B)
- Grant-in-Aid for Challenging Exploratory Research
- Grant-in-Aid for Early-Career Scientists
Zitieren
APA
Sugawara, R., Ito, H., Tabata, H., Ueda, H., Scala, M., & Nagata, K. I. (2024). The p.R66W Variant in RAC3 Causes Severe Fetopathy Through Variant-Specific Mechanisms. Cells. https://doi.org/10.3390/cells13232032
Vancouver
Sugawara R, Ito H, Tabata H, Ueda H, Scala M, Nagata KI. The p.R66W Variant in RAC3 Causes Severe Fetopathy Through Variant-Specific Mechanisms. Cells. 2024. doi:10.3390/cells13232032
BibTeX
@article{Sugawara2024,
author = {Sugawara, Ryota and Ito, Hidenori and Tabata, Hidenori and Ueda, Hiroshi and Scala, Marcello and Nagata, Koh-Ichi},
title = {The p.R66W Variant in RAC3 Causes Severe Fetopathy Through Variant-Specific Mechanisms},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13232032}
}
EUVIMED